(Reuters) – Billionaire entrepreneur Elon Musk’s brain-chip startup Neuralink said on Tuesday it has received approval from an independent review board to start the first human trial for its brain implant for paralysis patients.
(Reporting by Mariam Sunny in Bengaluru; Editing by Pooja Desai)